메뉴 건너뛰기




Volumn 13, Issue 4, 2011, Pages 412-415

Prevalence of potential cardiac resynchronization therapy candidates and actual use of cardiac resynchronization therapy in patients hospitalized for heart failure

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

EID: 79953145773     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq217     Document Type: Article
Times cited : (16)

References (9)
  • 1
    • 53549085406 scopus 로고    scopus 로고
    • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008
    • The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
    • Dickstein K, Cohen-Solal A, Filippatos G, McMurray J, Ponikowski P, Poole-Wilson P, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg S. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
    • (2008) Eur J Heart Fail , vol.10 , pp. 933-989
    • Dickstein, K.1    Cohen-Solal, A.2    Filippatos, G.3    McMurray, J.4    Ponikowski, P.5    Poole-Wilson, P.6    Strömberg, A.7    Van Veldhuisen, D.J.8    Atar, D.9    Hoes, A.W.10    Keren, A.11    Mebazaa, A.12    Nieminen, M.13    Priori, S.G.14    Swedberg, S.15
  • 3
    • 77950241880 scopus 로고    scopus 로고
    • Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: Systematic review and meta-analysis of randomized trials
    • Lubitz SA, Leong-Sit P, Fine N, Kramer DB, Singh J, Ellinor PT. Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials. Eur J Heart Fail 2010;12:360-366.
    • (2010) Eur J Heart Fail , vol.12 , pp. 360-366
    • Lubitz, S.A.1    Leong-Sit, P.2    Fine, N.3    Kramer, D.B.4    Singh, J.5    Ellinor, P.T.6
  • 4
    • 52049098291 scopus 로고    scopus 로고
    • Use of cardiac resynchronization therapy in patients hospitalized with heart failure
    • Fonarow GC from the Get with the Guidelines Steering Committee and Hospitals
    • Piccine JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, Peterson ED, Fonarow GC from the Get with the Guidelines Steering Committee and Hospitals. Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation 2008;118:926-933.
    • (2008) Circulation , vol.118 , pp. 926-933
    • Piccine, J.P.1    Hernandez, A.F.2    Dai, D.3    Thomas, K.L.4    Lewis, W.R.5    Yancy, C.W.6    Peterson, E.D.7
  • 5
    • 72949104923 scopus 로고    scopus 로고
    • Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: Changes from 2004 to 2008
    • Van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, Swedberg K. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009;11:1143-1151.
    • (2009) Eur J Heart Fail , vol.11 , pp. 1143-1151
    • Van Veldhuisen, D.J.1    Maass, A.H.2    Priori, S.G.3    Stolt, P.4    Van Gelder, I.C.5    Dickstein, K.6    Swedberg, K.7
  • 9
    • 36749074625 scopus 로고    scopus 로고
    • Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial
    • DOI 10.1016/j.cardfail.2007.07.012, PII S1071916407010214
    • Staszewsky L, Wong M, Masson S, Barlera S, Caretta E, Maggioni AP, Anand IS, Cohn JN, Tognoni G, Latini R. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT Heart Failure Trial. J Cardiac Fail 2007;13:797-804. (Pubitemid 350214524)
    • (2007) Journal of Cardiac Failure , vol.13 , Issue.10 , pp. 797-804
    • Staszewsky, L.1    Wong, M.2    Masson, S.3    Barlera, S.4    Carretta, E.5    Maggioni, A.P.6    Anand, I.S.7    Cohn, J.N.8    Tognoni, G.9    Latini, R.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.